Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
- Posted on July 21, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
July 21 (Reuters) - Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage trials, supporting regulatory filings for what could become the first regimen of its kind for the disease. Here are some details: • The combination of Merck's islatravir and Gilead's lenacapavir was tested as a single-tablet regimen in adults whose HIV
